68 Neoadjuvant MIP (mitomycin C+ ifosfamide + cisplatin) chemotherapy for non metastatic unresectable non small cell lung cancer (NSCLC): Are there prognostic factors for response obtention after three courses?

✍ Scribed by Paesmans, M.; Sculier, J.P.; Giner, V.; Bureau, G.; Lafitte, J.J.; Ninane, V.; Thiriaux, J.; Van Cutsem, O.; Mommen, P.; Van Houtte, P.; Klastersky, J.

• Book ID: 121996701
• Publisher: Elsevier Science
• Year: 1997
• Tongue: English
• Weight: 299 KB
• Volume: 18
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/S0169-5002(97)89347-6